russ2000_2_0189|CYCN|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
russ2000_2_0189|CYCN|Long Name|1|1|Cyclerion Therapeutics Inc Total Current Assets (Quarterly) (USD)|Cyclerion Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Cyclerion Therapeutics Inc Inventories (Quarterly) (USD)|Cyclerion Therapeutics Inc Net PP&E (Quarterly) (USD)|Cyclerion Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Deposits (Quarterly) (USD)|Cyclerion Therapeutics Inc Book Value (Quarterly) (USD)|Cyclerion Therapeutics Inc Retained Earnings (Quarterly) (USD)|Cyclerion Therapeutics Inc Treasury Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc EV to Revenues|Cyclerion Therapeutics Inc EV to Earnings|Cyclerion Therapeutics Inc EV to Free Cash Flow|Cyclerion Therapeutics Inc EV to Assets (Quarterly)|Cyclerion Therapeutics Inc PS Ratio|Cyclerion Therapeutics Inc PE Ratio|Cyclerion Therapeutics Inc Price to Book Value|Cyclerion Therapeutics Inc PEG Ratio|Cyclerion Therapeutics Inc Debt to Equity Ratio|Cyclerion Therapeutics Inc Dividend Yield|Cyclerion Therapeutics Inc Shareholder Yield (TTM)|Cyclerion Therapeutics Inc Percent of Shares Outstanding Short|Cyclerion Therapeutics Inc Total Receivables (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Payables (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc Return on Invested Capital|Cyclerion Therapeutics Inc Quality Ratio Score|Cyclerion Therapeutics Inc Momentum Score|Cyclerion Therapeutics Inc Beta (1Y)|Cyclerion Therapeutics Inc Sustainable Growth Rate (TTM)|Cyclerion Therapeutics Inc Institutional Investor Ownership Percentage|Cyclerion Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Cyclerion Therapeutics Inc Total Employees (Annual)|Cyclerion Therapeutics Inc EPS Diluted (Quarterly) (USD)|Cyclerion Therapeutics Inc Shares Outstanding|Cyclerion Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc Ordinary Shares Number (Quarterly)|Cyclerion Therapeutics Inc Payout Ratio|Cyclerion Therapeutics Inc Quick Ratio (Quarterly)|Cyclerion Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Cyclerion Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Cyclerion Therapeutics Inc Effective Tax Rate (TTM)|Cyclerion Therapeutics Inc Return on Equity|Cyclerion Therapeutics Inc Net Income (TTM) (USD)|Cyclerion Therapeutics Inc Revenue (TTM) (USD)|Cyclerion Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Cyclerion Therapeutics Inc Revenue (Quarterly) (USD)|Cyclerion Therapeutics Inc Gross Profit (Quarterly) (USD)|Cyclerion Therapeutics Inc SG&A Expense (Quarterly) (USD)|Cyclerion Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Net Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Net Interest Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Price (USD)|Cyclerion Therapeutics Inc Total Return Price (USD)|Cyclerion Therapeutics Inc Enterprise Value (USD)|Cyclerion Therapeutics Inc 30-Day Average Daily Volume|Cyclerion Therapeutics Inc 1 Year Price Returns (Daily)
russ2000_2_0189|CYCN|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
russ2000_2_0189|CYCN||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
russ2000_2_0189|CYCN||5|5|91.1666666667|91.1666666667|0|91.1666666667|0|91.1666666667|91.1666666667|91.1666666667|0|91.1666666667|91.1666666667|0|1.43055555556|91|1.43734643735|91.5|1.43055555556|0|1.44144144144|0|91.5|1.44088669951|91|15.2571428571|91.1666666667|91.1666666667|91.1666666667|91|0|30.6|30.5|91|30.5|91.3333333333|365|91.3333333333|31.3125|0|91.1666666667|91|91.5|91.3333333333|91.375|0|91|91.1666666667|91|0|91.5|0|91.3333333333|91.3333333333|91.3333333333|91.375|1.44088669951|1.44088669951|1.43734643735|1.44031830239|1.43137254902
russ2000_2_0189|CYCN||6|6|6|6|0|6|0|6|6|6|0|6|6|0|144|1|407|4|144|0|333|0|4|406|1|35|6|6|6|1|0|5|6|1|2|9|1|9|16|0|6|1|4|9|8|0|1|6|1|0|4|0|9|9|9|8|406|406|407|377|153
russ2000_2_0189|CYCN||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
russ2000_2_0189|CYCN|201803|201803|201803||||||||||||||||||||||||||||||||||27.304||-0.926||||||-0.926|||||||||3.769|-25.283|-25.283||||||
russ2000_2_0189|CYCN|201806|201806|201806||||||||||||||||||||||||||||||||||27.304||-1.0907||||||-1.0907|0||||||||7.53|-29.781|-29.781|0|||||
russ2000_2_0189|CYCN|201809|201809|201809||||||||||||||||||||||||||||||||||27.304||-1.0726||||||-1.0726|0||||||||7.787|-29.286|-29.286|0|||||
russ2000_2_0189|CYCN|201812|201812|201812|0.879|0||6.497||17.846|17.846|0||-10.445|0||||||||||||||0|2.781|0|||||||27.3045|140|-1.1318|||27.4112|||-1.1318|0|||-115.252|||||8.45|-30.902|-30.902|0|||||
russ2000_2_0189|CYCN|201903|201903|201903|0.939|||8.815||17.525|17.473|0.052||-7.752|||||-5.6886|||||||0||||5.671||||||||27.38||-1.37|27.3045||27.4017|||-1.37||||-127.35|||||10.977|-37.381|-37.381|0|21.03|21.03|574.2136||
russ2000_2_0189|CYCN|201904|201903|201903|||||||||||||||-3.7789|||||||0||4.9617|||||||||||||27.4017||||||||||||||||||15.23|15.23|417.3279|181996.7|
russ2000_2_0189|CYCN|201905|201903|201903|||||||||||||||-3.4613|||||||0||5.3506|||||||||||||27.4017||||||||||||||||||13.95|13.95|382.2537|128350.4333|
russ2000_2_0189|CYCN|201906|201906|201906|144.693|141.03||83.084||94.313|21.916|72.397||141.19|-32.254||||-1.5196|0.7339|||||0|0||3.3315|1.857|8.783|0|||||||27.393||-1.18|27.4112||27.4112||6.5198|-1.18|-175|||-129.823|||1.628||8.923|-32.254|-32.254|0.8|11.45|11.45|172.8282|235103.3|
russ2000_2_0189|CYCN|201907|201906|201906|||||||||||||||-0.999||||1.8036|||0||3.9445|||||||||||||||||||||||||||||||9.29|9.29|113.62|205720.8667|
russ2000_2_0189|CYCN|201908|201906|201906|||||||||||||||-1.0528||||1.847|||0||3.9782|||||||||||||27.4209||||||||||||||||||9.51|9.51|119.7428|97994.2|
russ2000_2_0189|CYCN|201909|201909|201909|120.706|117.034||81.272||90.507|19.096|71.411||119.197|-59.572||||-1.9321|1.0295|||2.793||0|0||4.4921|1.44|5.005|0|||||||27.434||-1|27.4684||27.4684||6.2041|-1|0|||-127.854|||1.398||7.119|-27.317|-27.317|0.699|12.12|12.12|215.883|120432.1333|
russ2000_2_0189|CYCN|201910|201909|201909|||||||||||||||0.4599||||0.5508|||0||4.5993|||||||||||||||||||||||||||||||2.39|2.39|-51.3845|407597.4333|
russ2000_2_0189|CYCN|201911|201909|201909|||||||||||||||0.5926||||0.4263|||0||4.5982|||||||||||||27.4689||||||||||||||||||1.85|1.85|-66.2165|938891.5333|
russ2000_2_0189|CYCN|201912|201912|201912|101.197|94.895||79.75||88.749|18.249|70.5||97.729|-85.627||||0.1817|-0.1063|||0.7681||0|0||2.8119|1.474|3.311|0|||||||27.38|94|-0.95|27.5981||27.5981||5.2808|-0.95|0|||-123.007|||1.481||7.385|-26.055|-26.055|0.531|2.72|2.72|-19.8282|900320.8|
russ2000_2_0189|CYCN|202001|201912|201912|||||||||||||||0.0401||||0.9263|||0||5.802|||||||||||||||||||||||||||||||3.28|3.28|-4.3732|821844.8|
russ2000_2_0189|CYCN|202002|201912|201912|||||||||||||||-0.2129||||1.2086|||0||7.0174|||||||||||||||||||||||||||||||4.28|4.28|23.2249|576689.7333|
russ2000_2_0189|CYCN|202003|202003|202003|70.126|67.096||63.854||58.49|11.435|47.055||81.54|-105.855||1.1691|-0.061|-0.0623|0.0461|13.1847||0.902||0|0|-237.9318|5.4076|1.026|1.522|0|-96.3062|||-0.2716|-122.5434||27.669||-0.73|27.7549||27.7549|0|5.9573|-0.8064|||-122.5434|-105.854|5.521||1.014||6.891|-20.228|-20.228|0.361|2.65|2.65|6.4545|545970.9667|-87.399
russ2000_2_0189|CYCN|202004|202003|202003|||||||||||||7.3022||-0.3891||19.2547||1.3173|||0||4.5024||||||1|1.2695||||||||||||||||||||||||3.87|3.87|40.3155|260944.6667|-74.5896
russ2000_2_0189|CYCN|202005|202003|202003|||||||||||||7.8552||-0.4186||19.802||1.3547|||0||3.5676||||||2|1.2725||||||27.7549||||||||||||||||||3.98|3.98|43.3685|175398.2|-71.5714
russ2000_2_0189|CYCN|202006|202006|202006|59.562|56.462||62.093||61.937|15.645|46.292||66.101|-125.389||24.0599|-1.1992|-1.2182|0.8723|35.0991||2.4907||0.0531|0|-0.4263|3.7434|0.751|2.588|0|-91.4394||1|1.7627|-92.0739||27.791||-0.7|27.8577||27.8577|0|3.657|-0.7|0||-92.0739|-93.134|4.642||0.749||6.627|-19.534|-19.534|0.138|5.91|5.91|111.686|278370.5667|-48.3843
russ2000_2_0189|CYCN|202007|202006|202006|||||||||||||16.5063||-0.8357||22.6867||1.9603|||0||2.4748||||||2|1.2969||96.224||||33.9202||||||||||||||||||3.82|3.82|76.6222|333869.6333|-58.8805
russ2000_2_0189|CYCN|202008|202006|202006|||||||||||||38.428||-1.9456||40.5035||3.4997|||0||2.6917||||||2|2.0428||96.3784||||||||||||||||||||||6.82|6.82|178.3828|306303|-28.286
russ2000_2_0189|CYCN|202009|202009|202009|||||||||||||33.0206||-1.6719||36.1087||3.12|||0||2.765||||||3|2.1254||91.605||||||||||||||||||||||6.08|6.08|153.2818|255931.0667|-49.835
russ2000_2_0189|CYCN|202010|202009|202009|||||||||||||7.8837||-0.3992||15.6788||1.3547|||0|||||||||||||||||||||||||||||||||2.64|2.64|36.5963|724568.3667|-75.9124